Helen Eagleton
Impact in
- Hematology top 10%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
-
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
-
- Acute Myeloid Leukemia Research 5
- Erythropoietin and Anemia Treatment 1
- Platelet Disorders and Treatments 1
- Genetics 2
- Myeloproliferative Neoplasms: Diagnosis and Treatment 2
- Co-authors
- Jacqueline Boultwood (5 shared papers)James S. Wainscoat (5 shared papers)Andrea Pellagatti (4 shared papers)Cordelia F. Langford (2 shared papers)Carrie Fidler (5 shared papers)David L.P. Vetrie (2 shared papers)Timothy James Littlewood (2 shared papers)Tim J. Littlewood (4 shared papers)
- Journals
- British Journal of Haematology (6 papers)Blood (1 paper)Journal of Clinical Oncology (1 paper)European Journal Of Haematology (1 paper)Leukemia (1 paper)
- Partner nations
- United KingdomCroatia
In The Last Decade
Helen Eagleton
14 papers receiving 319 citations
Peers
Comparison fields: 5 of 43
- Hematology 144
- Genetics 44
- Internal Medicine 7
- Immunology 41
- Pathology and Forensic Medicine 30
Countries citing papers authored by Helen Eagleton
This map shows the geographic impact of Helen Eagleton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Eagleton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Eagleton more than expected).
Fields of papers citing papers by Helen Eagleton
This network shows the impact of papers produced by Helen Eagleton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Eagleton. The network helps show where Helen Eagleton may publish in the future.
Co-authors
The 25 scholars most cited alongside Helen Eagleton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 69 | |
| 2 | Gene expression profiling in polycythemia vera using cDNA microarray technology. | 2003 | 44 |
| 3 | 2006 | 44 | |
| 4 | 2020 | 40 | |
| 5 | 2003 | 31 | |
| 6 | 2024 | 30 | |
| 7 | 2006 | 23 | |
| 8 | 2004 | 14 | |
| 9 | 2004 | 12 | |
| 10 | Update on the clinical use and misuse of erythropoietin. | 2003 | 11 |
| 11 | 2016 | 5 | |
| 12 | 2015 | 3 | |
| 13 | 2004 | 1 | |
| 14 | Neutrophil PRV-1 gene expression in myeloproliferative, myelodysplastic and reactive blood disorders | 2004 | 1 |
| 15 | 2011 | 0 |
About Helen Eagleton
Helen Eagleton is a scholar working on Hematology, Genetics, Pathology and Forensic Medicine, Physiology and Gastroenterology, having authored 15 papers that have together received 328 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers), Telomeres, Telomerase, and Senescence (2 papers), Lymphoma Diagnosis and Treatment (2 papers), Erythropoietin and Anemia Treatment (1 paper), Atrial Fibrillation Management and Outcomes (1 paper), Medical Imaging Techniques and Applications (1 paper) and Platelet Disorders and Treatments (1 paper). The work is most often cited by research in Hematology (144 citations), Genetics (44 citations), Internal Medicine (7 citations), Immunology (41 citations) and Pathology and Forensic Medicine (30 citations). Helen Eagleton has collaborated with scholars based in United Kingdom and Croatia. Frequent co-authors include Jacqueline Boultwood, James S. Wainscoat, Andrea Pellagatti, Cordelia F. Langford, Carrie Fidler, David L.P. Vetrie, Timothy James Littlewood, Tim J. Littlewood, Fiona Watkins and Barrie E. Woodcock. Their work appears in journals such as British Journal of Haematology, Blood, Journal of Clinical Oncology, European Journal Of Haematology and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.